A bill to prohibit the marketing of bogus opioid treatment programs or products.
Opioid Addiction Recovery Fraud Prevention Act of 2018
This bill prohibits deceptive representation regarding the cost, price, efficacy, performance, benefit, risk, or safety of opioid treatment programs or products.
Became Public Law No: 115-271.
Introduced in Senate
Read twice and referred to the Committee on Commerce, Science, and Transportation.
Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment in the nature of a substitute favorably.
Committee on Commerce, Science, and Transportation. Reported by Senator Thune with an amendment in the nature of a substitute. With written report No. 115-285.
Committee on Commerce, Science, and Transportation. Reported by Senator Thune with an amendment in the nature of a substitute. With written report No. 115-285.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 490.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line